School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Lantheus Holdings, Inc. LNTH

Healthcare · Drug Manufacturers - Specialty & Generic

$100.15last close 2026-10-09 · market cap $6.54B · delayed data

Trailing returns

1M-0.55%
3M-5.51%
6M+22.99%
1Y+91.16%
5Y+322.04%

Basis: Adjusted daily closes.

What it does

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

Open LNTH in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies